Knowledge Graphs for Drug Resistance Data Representation

This study presents a comprehensive framework utilizing knowledge graphs (KGs) to revolutionize the understanding and management of drug resistance patterns. By leveraging the BERT language model, we developed a novel method for extracting and connecting drug resistance information from scientific literature with unprecedented accuracy. Our method combines several data types into a single KG structure, including protein interactions, genetic markers, and clinical trial results. Through this integration, possible medication synergies and minor resistance patterns that conventional analytical approaches can miss can be found. When compared to manual expert annotation, the BERT-based extraction technique outperformed the latter in capturing intricate drug-pathogen relationships, attaining 92% accuracy in connection identification. The practical value of the KG was validated clinically through controlled trials conducted at three major medical institutes. When utilizing our approach, healthcare providers reported a 35% increase in treatment plan optimization and a 40% reduction in the amount of time spent examining resistance patterns. When it came to anticipating cross-resistance events and figuring out alternate treatment approaches for situations of multi-drug resistance, the KG framework performed exceptionally well. Additionally, by exposing hitherto unknown connections between resistance mechanisms and biochemical pathways, the method made it easier to identify new drug targets. Three intriguing treatment possibilities are now undergoing preclinical studies because of this. Our KG is dynamic, enabling real-time updates when new resistance patterns appear, making it a continuously changing tool for clinical decision-making. This study shows how KG-based strategies can revolutionize drug resistance issues by providing a scalable alternative for evidence-based healthcare decision-making and expedited medication development.

Authors

Institutions

Publication Details

Published
2024-12-03
DOI
https://doi.org/10.1109/bibm62325.2024.10822289
Primary Topic
Computational Drug Discovery Methods
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Knowledge Graphs for Drug Resistance Data Representation

Liang Xiao, Eastgar Garmonee Sarkpa
Computational Drug Discovery Methods
article

Knowledge Graphs for Drug Resistance Data Representation

Liang Xiao, Eastgar Garmonee Sarkpa
article en

Abstract

This study presents a comprehensive framework utilizing knowledge graphs (KGs) to revolutionize the understanding and management of drug resistance patterns. By leveraging the BERT language model, we developed a novel method for extracting and connecting drug resistance information from scientific literature with unprecedented accuracy. Our method combines several data types into a single KG structure, including protein interactions, genetic markers, and clinical trial results. Through this integration, possible medication synergies and minor resistance patterns that conventional analytical approaches can miss can be found. When compared to manual expert annotation, the BERT-based extraction technique outperformed the latter in capturing intricate drug-pathogen relationships, attaining 92% accuracy in connection identification. The practical value of the KG was validated clinically through controlled trials conducted at three major medical institutes. When utilizing our approach, healthcare providers reported a 35% increase in treatment plan optimization and a 40% reduction in the amount of time spent examining resistance patterns. When it came to anticipating cross-resistance events and figuring out alternate treatment approaches for situations of multi-drug resistance, the KG framework performed exceptionally well. Additionally, by exposing hitherto unknown connections between resistance mechanisms and biochemical pathways, the method made it easier to identify new drug targets. Three intriguing treatment possibilities are now undergoing preclinical studies because of this. Our KG is dynamic, enabling real-time updates when new resistance patterns appear, making it a continuously changing tool for clinical decision-making. This study shows how KG-based strategies can revolutionize drug resistance issues by providing a scalable alternative for evidence-based healthcare decision-making and expedited medication development.

Hubei University of Technology (CN)
Openalex Percentile: Top 70%
Computational Drug Discovery Methods
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.